<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-01T02:17:47Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/38172" metadataPrefix="qdc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/38172</identifier><datestamp>2026-02-03T11:17:16Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37953</setSpec></header><metadata><qdc:qualifieddc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Cross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein.</dc:title>
   <dc:creator>Burnap, Sean A.</dc:creator>
   <dc:creator>Ortega-Prieto, Ana María</dc:creator>
   <dc:creator>Jimenez-Guardeño, Jose Manuel</dc:creator>
   <dc:creator>Ali, Hashim</dc:creator>
   <dc:creator>Takov, Kaloyan</dc:creator>
   <dc:creator>Fish, Matthew</dc:creator>
   <dc:creator>Shankar-Hari, Manu</dc:creator>
   <dc:creator>Giacca, Mauro</dc:creator>
   <dc:creator>Malim, Michael H.</dc:creator>
   <dc:creator>Mayr, Manuel</dc:creator>
   <dc:subject>COVID-19 - Aspectos moleculares</dc:subject>
   <dc:subject>Virología</dc:subject>
   <dcterms:abstract>High-density lipoprotein (HDL) levels are reduced in patients with coronavirus disease 2019 (COVID-19), and the extent of this reduction is associated with poor clinical outcomes. While lipoproteins are known to play a key role during the life cycle of the hepatitis C virus, their influence on coronavirus (CoV) infections is poorly understood. In this study, we utilize cross-linking mass spectrometry (XL-MS) to determine circulating protein interactors of the severe acute respiratory syndrome (SARS)-CoV-2 spike glycoprotein. XL-MS of plasma isolated from patients with COVID-19 uncovered HDL protein interaction networks, dominated by acute-phase serum amyloid proteins, whereby serum amyloid A2 was shown to bind to apolipoprotein (Apo) D. XL-MS on isolated HDL confirmed ApoD to interact with SARS-CoV-2 spike but not SARS-CoV-1 spike. Other direct interactions of SARS-CoV-2 spike upon HDL included ApoA1 and ApoC3. The interaction between ApoD and spike was further validated in cells using immunoprecipitation-MS, which uncovered a novel interaction between both ApoD and spike with membrane-associated progesterone receptor component 1. Mechanistically, XL-MS coupled with data-driven structural modeling determined that ApoD may interact within the receptor-binding domain of the spike. However, ApoD overexpression in multiple cell-based assays had no effect upon viral replication or infectivity. Thus, SARS-CoV-2 spike can bind to apolipoproteins on HDL, but these interactions do not appear to alter infectivity.</dcterms:abstract>
   <dcterms:dateAccepted>2025-03-20T07:47:31Z</dcterms:dateAccepted>
   <dcterms:available>2025-03-20T07:47:31Z</dcterms:available>
   <dcterms:created>2025-03-20T07:47:31Z</dcterms:created>
   <dcterms:issued>2023</dcterms:issued>
   <dc:type>journal article</dc:type>
   <dc:identifier>https://hdl.handle.net/10630/38172</dc:identifier>
   <dc:identifier>10.1016/j.mcpro.2023.100600</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:rights>Attribution 4.0 Internacional</dc:rights>
   <dc:publisher>Elsevier</dc:publisher>
</qdc:qualifieddc>
</metadata></record></GetRecord></OAI-PMH>